Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Eichelbaum

Showing results (21-30 of 263) with videos related to

Pageof 27
Sort By:
Nature Medicine|March 7, 2001
CYP3A genetics in drug metabolismM Eichelbaum, O Burk
The Pharmacogenomics Journal|March 27, 2002
Polymorphisms in the ABC drug transporter gene MDR1U Brinkmann, M Eichelbaum
Journal of Cardiovascular Pharmacology|January 1, 1984
Clinical pharmacology of calcium antagonists: a critical reviewM Eichelbaum, H Echizen
Arzneimittel-Forschung|January 1, 1977
Determination of verapamil in human plasma by mass fragmentography using stable isotope-labelled verapamil as internal standardB Spiegelhalder, M Eichelbaum
Clinical Pharmacokinetics|November 1, 1986
Clinical pharmacokinetics of verapamil, nifedipine and diltiazemH Echizen, M Eichelbaum
Leber, Magen, Darm|April 1, 1981
[Drug dosing in chronic hepatic disease (author's transl)]R Gugler, M Eichelbaum
Journal of Chromatography|January 14, 1975
Determination of carbamazepine and its epoxide metabolite in plasma by high-speed liquid chromatographyM Eichelbaum, L Bertilsson
Der Internist|May 8, 2000
[Fundamentals of pharmacotherapy and pharmacokinetic principles]K Mörike, M Eichelbaum
British Journal of Clinical Pharmacology|April 1, 1993
The metabolism of aprindine in relation to the sparteine/debrisoquine polymorphismT Ebner, M Eichelbaum
Pharmacology & Therapeutics|January 1, 1990
The genetic polymorphism of debrisoquine/sparteine metabolism--clinical aspectsM Eichelbaum, A S Gross
Pageof 27

Showing results (21-30 of 263) with videos related to

Sort By:
Pageof 27
Nature Medicine|March 7, 2001
CYP3A genetics in drug metabolismM Eichelbaum, O Burk
The Pharmacogenomics Journal|March 27, 2002
Polymorphisms in the ABC drug transporter gene MDR1U Brinkmann, M Eichelbaum
Journal of Cardiovascular Pharmacology|January 1, 1984
Clinical pharmacology of calcium antagonists: a critical reviewM Eichelbaum, H Echizen
Arzneimittel-Forschung|January 1, 1977
Determination of verapamil in human plasma by mass fragmentography using stable isotope-labelled verapamil as internal standardB Spiegelhalder, M Eichelbaum
Clinical Pharmacokinetics|November 1, 1986
Clinical pharmacokinetics of verapamil, nifedipine and diltiazemH Echizen, M Eichelbaum
Leber, Magen, Darm|April 1, 1981
[Drug dosing in chronic hepatic disease (author's transl)]R Gugler, M Eichelbaum
Journal of Chromatography|January 14, 1975
Determination of carbamazepine and its epoxide metabolite in plasma by high-speed liquid chromatographyM Eichelbaum, L Bertilsson
Der Internist|May 8, 2000
[Fundamentals of pharmacotherapy and pharmacokinetic principles]K Mörike, M Eichelbaum
British Journal of Clinical Pharmacology|April 1, 1993
The metabolism of aprindine in relation to the sparteine/debrisoquine polymorphismT Ebner, M Eichelbaum
Pharmacology & Therapeutics|January 1, 1990
The genetic polymorphism of debrisoquine/sparteine metabolism--clinical aspectsM Eichelbaum, A S Gross
Pageof 27